Cancan Diagnostics, a company dedicated to advancing canine health, has recently announced a strategic distribution partnership with Vet Planet Ltd., a leading provider of veterinary products and services based in Poland. This collaboration will make Cancan’s revolutionary diagnostic tools for canine cancer available across Mainland Europe, APAC, Middle East and South America, reaching a total of 47 territories.
Cancan’s mission is to improve the accuracy and speed of cancer diagnosis in dogs through their cutting-edge diagnostic solution, K9-LiquiDX™. This revolutionary tool is the world’s first test designed specifically for minimal residual disease testing in dogs, offering unparalleled early relapse detection and support for monitoring canine cancer.
The partnership with Vet Planet Ltd. marks a significant milestone in Cancan’s global expansion, ensuring that veterinarians worldwide have access to innovative tools that enhance the overall experience for pets and their owners. Through this partnership, Cancan’s products will be distributed to veterinarians across 47 territories, providing them with advanced diagnostic solutions to improve the detection and management of cancer in dogs.
“We are thrilled to partner with Vet Planet Ltd., a highly respected name in the European veterinary market,” said Dr. Maciej Parys, CEO and Founder of Cancan Diagnostics. “Their extensive distribution network and dedication to veterinary excellence align perfectly with our mission to improve canine cancer care through advanced diagnostics. Together, we can make a substantial impact on the detection and management of cancer in dogs worldwide.”
Vet Planet Ltd., known for its exceptional service and commitment to the veterinary community, will play a crucial role in ensuring that Cancan Diagnostics’ innovative products reach veterinarians across 47 territories. This partnership reflects a shared vision of enhancing pet health through advanced, reliable, and accessible diagnostic solutions.
Lukasz Deneka, DVM, Category Development Manager of Diagnostics at Vet Planet Ltd., stated, “Vet Planet Ltd.’s brand, Vet Expert, incorporates the term ‘Based on evidence’ in its logo. This statement reflects our approach of developing innovative products and solutions that are not only effective but also first in their class. Our partnership with Cancan Diagnostics perfectly aligns with our mission of caring for animal health and welfare. The cooperation will certainly enrich our offer with a cutting-edge diagnostic solution, which will be distributed by Vet Planet Ltd. under the name of Vet Expert K9-LiquiDX Canine Cancer Check.”
Cancan Diagnostics and Vet Planet Ltd. are excited to work closely together to empower veterinarians with the tools they need to make a real difference in the lives of dogs affected by cancer.
For more information about Cancan Diagnostics and its innovative solutions, please visit cancandiagnostics.com.
About Cancan Diagnostics
Cancan Diagnostics is a spin-out from the University of Edinburgh, specializing in innovative solutions for the diagnosis and monitoring of canine cancer. With a focus on improving pet health outcomes, Cancan’s products empower veterinarians with the latest technology to diagnose and manage cancer in dogs more effectively.
For more information, please contact:
Email: enquiries@cancandiagnostics.com
About Vet Planet Ltd.
Vet Planet Ltd. was established in 2008 with a mission to support pet parents and veterinarians in their everyday decisions regarding care and treatment. The company is known and valued in over 45 countries around the world and has been listed among the TOP 5 most innovative companies in the PET Industry (GlobalPETS Forum 2024).
For more information, please contact:
Email: diagnostyka@vetexpert.pl
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.